Cell-mediated graft rejection observed in two lines of human histocompatibility leukocyte antigen class I transgenic mice

被引:4
作者
Ando, Y
Beck, Y
Tomikawa, S
Eriguchi, M
Muto, T
Takiguchi, M
机构
[1] Univ Tokyo, Inst Med Sci, Dept Surg & Transplantat, Minato Ku, Tokyo 1088639, Japan
[2] Kumamoto Univ, Ctr AIDS Res, Div Viral Immunol, Kumamoto 862, Japan
关键词
D O I
10.1097/00007890-199909270-00026
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Human histocompatibility leukocyte antigen (HLA) class I molecules are essential for graft rejection. However, to determine the specific role of these molecules in clinical situations is difficult. We investigated the applicability of HLA class I transgenic mice (C3H.B35 and C3H.B51) for elucidation of the role of HLA class I molecules. Methods. Skin or heart grafts were transplanted. Cytotoxic T cells (CTL) of C3H.B51 against C3H.B35 were generated and their cytotoxicity against various transfectant cell lines mas determined. Results. C3H.B35 skin and heart grafted 60 C3H.B51 were rejected within 17 and 28 days, respectively. Cytotoxic T cells generated from C3H.B51 showed cytotoxicity against a HLA-B*3501-transfectant cell line that did not express H-2 molecule, which indicates that these cytotoxic T cells recognize HLA-B35 molecules directly without H-2 restriction. Conclusion. Our results suggest that C3H.B51 recognize C3H.B35 grafts as allo-MHC class I-incompatible grafts, and these mice are valuable to elucidate the role of HLA class I molecules in transplantation.
引用
收藏
页码:904 / 908
页数:5
相关论文
共 10 条
  • [1] BARRA C, 1993, J IMMUNOL, V150, P3681
  • [2] BILLINGHAM RE, 1951, J EXP BIOL, V28, P385
  • [3] PRIMARILY VASCULARIZED ALLOGRAFTS OF HEARTS IN MICE - ROLE OF H-2D, H-2K, AND NON-H-2 ANTIGENS IN REJECTION
    CORRY, RJ
    WINN, HJ
    RUSSELL, PS
    [J]. TRANSPLANTATION, 1973, 16 (04) : 343 - 350
  • [4] HAMERLING GJ, 1990, P NATL ACAD SCI USA, V87, P235
  • [5] STRONG XENOGENEIC HLA RESPONSE IN TRANSGENIC MICE AFTER INTRODUCING AN ALPHA-3 DOMAIN INTO HLA-B27
    KALINKE, U
    ARNOLD, B
    HAMMERLING, GJ
    [J]. NATURE, 1990, 348 (6302) : 642 - 644
  • [6] KARAKI S, 1993, IMMUNOGENETICS, V37, P139
  • [7] THE STRUCTURE OF HLA-B35 SUGGESTS THAT IT IS DERIVED FROM HLA-BW58 BY 2 GENETIC MECHANISMS
    OOBA, T
    HAYASHI, H
    KARAKI, S
    TANABE, M
    KANO, K
    TAKIGUCHI, M
    [J]. IMMUNOGENETICS, 1989, 30 (02) : 76 - 80
  • [8] CHEMISTRY OF PEPTIDES ASSOCIATED WITH MHC CLASS-I AND CLASS-II MOLECULES
    RAMMENSEE, HG
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (01) : 85 - 96
  • [9] Identification of HTLV-1-specific CTL directed against synthetic and naturally processed peptides in HLA-B*3501 transgenic mice
    Schonbach, C
    Nokihara, K
    Bangham, CRM
    Kariyone, A
    Karaki, S
    Shida, H
    Takatsu, K
    Egawa, K
    Wiesmuller, KH
    Takiguchi, M
    [J]. VIROLOGY, 1996, 226 (01) : 102 - 112
  • [10] Zinkernagel R M, 1979, Adv Immunol, V27, P51, DOI 10.1016/S0065-2776(08)60262-X